Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
FACTBOX-Brokerages expect global growth to slow in late 2025 on tariffs, geopolitical tensions
August 8 (Reuters) - Major brokerages, including Goldman Sachs, J.P.Morgan and Morgan Stanley, have forecast slower global growth for late 2025 due to economic uncertainty fueled by tariffs and geopolitical tensions. The U.S. economy is expected to grow between 1% and 2% this year, according to est...
Reuters
Fri, Aug 8
Why Centrus Energy Stock Is Powering Higher This Week
Key PointsCentrus Energy reported strong second-quarter 2025 financial results this week.A Northland analyst revealed a bullish price target on Centrus stock.Potential investors should do their due diligence on the company instead of weighing analysts' price targets too heavily.10 stocks we like bet...
The Motley Fool
Fri, Aug 8
1 Green Flag for Target Stock Right Now
Key PointsTarget has posted several quarters of same-store-sales declines since 2023.The company's been willing and able to evolve in an effort to turn its business around. This stock's multiyear sell-off may now be an opportunity for risk-tolerant investors.10 stocks we like better than Target › Wi...
The Motley Fool
Fri, Aug 8
Revelation Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Revelation Biosciences Inc REVB.OQ reported a quarterly adjusted loss of $7.01 per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-246.24. The mean expectation of two analysts for the quarter was for a loss of $20.64 per share. Wall...
Reuters
Fri, Aug 8
Ensysce Biosciences Inc
expected to post a loss of $1.18 a share - Earnings Preview
Ensysce Biosciences Inc ENSC.OQ ENSC.O is expected to show a rise in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025The La Jolla California-based company is expected to report a 257.5% increase in revenue to $650 thousand from $181.8 thousand ...
Reuters
Fri, Aug 8
Italian Sea Group lowers 2025 guidance on US tariffs, shares down 9.7%
Aug 8 (Reuters) - Shares in The Italian Sea Group TISGR.MI fell as much as 9.7% after the group cut its 2025 revenue and core profit margin forecast on Friday, citing U.S. protectionist trade policies and ongoing geopolitical tension.The luxury yacht maker now expects 2025 revenue of 350 million eur...
Reuters
Fri, Aug 8
Hudson Global (HSON) Q2 Revenue Tops 3%
Key PointsEarnings per share (non-GAAP) were $0.12, missing the analyst estimate of $0.17 for Q2 2025 and falling short by 29.4%.Revenue (GAAP) reached $35.5 million in Q2 2025, exceeding expectations and reflecting stable client activity despite a slight year-over-year decrease.Adjusted EBITDA (non...
The Motley Fool
Fri, Aug 8
United-Guardian (UG) Q2 Sales Drop 16%
Key PointsDistributor inventory overhang weighed heavily on cosmetic ingredients sales, despite growth in pharmaceutical and medical lubricant products during the first six months of 2025 compared to the same period in 2024.Management did not provide forward financial guidance and signaled uncertain...
The Motley Fool
Fri, Aug 8
LIVE MARKETS-Nasdaq Composite: New highs, but sputtering thrust is a concern
US equity index futures modestly greenEuro STOXX 600 index up ~0.1%Dollar rallies; crude gains; gold edges down; bitcoin slipsUS 10-Year Treasury yield edges up to ~4.27%Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at ...
Reuters
Fri, Aug 8
Microchip Technology (MCHP) Q1 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Motley Fool.DATEThursday, Aug. 7, 2025 at 5 p.m...
The Motley Fool
Fri, Aug 8
Does This $856 Million Investment Make Eli Lilly Stock a Buy?
Key PointsEli Lilly is investing money to help a smaller biotech develop a new class of small-molecule drugs.This move is another in a long list of deals it has made recently to strengthen its operations. Lilly's commitment to improving its already strong business makes the stock attractive.10 stock...
The Motley Fool
Fri, Aug 8
Here's Why I Remain Bullish on AMD Despite the Dip After Earnings
In this video, I will go over Advanced Micro Devices' (NASDAQ: AMD) earnings report and explain what the market missed and why I remain extremely bullish. Watch the short video to learn more, consider subscribing, and click the special offer link below.*Stock prices used were from the trading day of...
The Motley Fool
Fri, Aug 8
DXC Opens New Office in Buenos Aires, Reinforces Commitment to Growth in Latin America
ASHBURN, Va., Aug. 8, 2025 /CNW/ - DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the official opening of its new office in Buenos Aires, Argentina, further expanding its footprint in Latin America. Located in Capital Federal, the modern facili...
PR Newswire
Fri, Aug 8
Calumet (CLMT) Q2 Revenue Tops by 11%
Key PointsRevenue (GAAP) exceeded estimates by 10.96% in Q2 2025, but the net loss was much larger than expected at $(1.70) per share (GAAP) in Q2 2025.Adjusted EBITDA dropped 26% year-over-year, but company-wide cost cuts delivered $42 million in savings in the first half of 2025.Montana Renewables...
The Motley Fool
Fri, Aug 8
Capricor Therapeutics rises on meeting with US FDA for muscle disorder therapy
** Shares of therapy developer Capricor Therapeutics CAPR.O up 3.22% at $8.33 premarket** Co says meeting with U.S. FDA has been scheduled to discuss regulatory path of its cell therapy for treatment of cardiomyopathy associated with Duchenne muscular dystrophy, which is type of muscle disorder** To...
Reuters
Fri, Aug 8
GT Biopharma Inc
expected to post a loss of 68 cents a share - Earnings Preview
GT Biopharma Inc GTBP.OQ GTBP.O is expected to report resultson August 12 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for GT Biopharma Inc is for a loss of 68 cents per share. The one available analyst rating on the shares is "buy". The mean earnings est...
Reuters
Fri, Aug 8
Musk Orders Dojo Team Disbanded, Marking a Strategic Shift in Tesla’s AI Ambitions
TradingKey - Tesla is undergoing a major shake-up in its AI strategy. Multiple media outlets, citing people familiar with the matter, report that Elon Musk has ordered the shutdown of the company’s in-house Dojo supercomputer project. Peter Bannon
Tesla Inc
TradingKey
Fri, Aug 8
BioCardia Inc
expected to post a loss of 50 cents a share - Earnings Preview
BioCardia Inc BCDA.OQ BCDA.O is expected to show a fall in quarterly revenue when it reports results on August 11 for the period ending June 30 2025LSEG's mean analyst estimate for BioCardia Inc is for a loss of 50 cents per share. The one available analyst rating on the shares is "buy...
Reuters
Fri, Aug 8
Rocket Lab (RKLB) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Motley Fool.DateAug. 7, 2025 at 5:00 p.m. ETCal...
The Motley Fool
Fri, Aug 8
US STOCKS-Wall St set for higher open as Fed shake-up stokes dovish bets
Futures up: Dow 0.14%, S&P 500 0.2%, Nasdaq 0.14% Pinterest falls after missing Q2 profit estimatesFed's Alberto Musale due to speak later in the dayTrade Desk slumps after slower Q2 revenue growthBy Nikhil Sharma and Pranav Kashyap Aug 8 (Reuters) - Wall Street's main indexes l...
Reuters
Fri, Aug 8
1
...
567
568
569
569
/
4211
570
571
...
4211
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up